OMIC Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 jun 2024 @ 22:00):
Our systems believe the stock currently is undervalued by 0.55% compare to its pairs and should correct upwards.

Stats
Dagens volum	18 861
Gjennomsnittsvolum	5 536
Markedsverdi	20.87M
EPS	$-0.340 ( Q1 \| 2024-05-14 )
Neste inntjeningsdato	( $-8.88 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.220 (Sector) 42.63 (Industry) 78.56
ATR14	$0.222 (2.61%)

GCTK 0.50%

GMVDW -1.13%

LUCY 50.00%

LUCYW 2.97%

NXGLW 0.00%

NYXH -0.57%

OMIC -9.33%

POCI 0.51%

Insider Trading

Date	Person	Action	Amount	type
2024-06-15	Meeter Dalen	Buy	6 250	Common Stock
2024-06-15	Meeter Dalen	Sell	6 250	Restricted Stock Units
2024-06-15	Glezer Eli N.	Buy	7 500	Common Stock
2024-06-15	Glezer Eli N.	Sell	7 500	Restricted Stock Units
2024-06-15	Spaventa Andrew	Buy	14 584	Common Stock

INSIDER POWER
44.10
Last 98 transactions
Buy: 5 152 178 \| Sell: 2 090 858

Korrelasjon (AI algo v.1.1b): Undervalued: 0.55% $8.55 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.04 (neutral)

Kort: -0.54 (weak negative)

Signal:(36.887) Neutral

Singular Genomics Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Singular Genomics Korrelasjon - Valuta/Råvare

-0.16
( neutral )

-0.39
( neutral )

0.04
( neutral )

-0.11
( neutral )

-0.39
( neutral )

0.53
( weak )

Singular Genomics Økonomi

Annual	2023
Omsetning:	$2.91M
Bruttogevinst:	$-558 000 (-19.17 %)
EPS:	$-1.300

FY	2023
Omsetning:	$2.91M
Bruttogevinst:	$-558 000 (-19.17 %)
EPS:	$-1.300

FY	2022
Omsetning:	$765 000
Bruttogevinst:	$-24 000.00 (-3.14 %)
EPS:	$-1.240

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.377

Financial Reports:

No articles found.

Singular Genomics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Singular Genomics

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.